As of April 16, 2025, Tarsus Pharmaceuticals (TARS) has a market cap of $2.04 billion USD. According to our data, Tarsus Pharmaceuticals is ranked No.3944 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $2.04 B |
-3.44%
|
Dec 31, 2024 | $2.12 B |
173.43%
|
Dec 29, 2023 | $0.77 B |
38.13%
|
Dec 30, 2022 | $0.56 B |
-34.84%
|
Dec 31, 2021 | $0.86 B |
-45.56%
|
Dec 31, 2020 | $1.58 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Ocular Therapeutix
OCUL
|
$1.20 B |
-0.000 M
|
![]() USA
|
![]() Kala Pharmaceuticals
KALA
|
$22.78 M |
0.000 M
|
![]() USA
|
![]() Aldeyra Therapeutics
ALDX
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Santen Pharmaceutical
4536.T
|
$3.27 B |
68.032 M
|
![]() Japan
|
![]() Bausch Health
BHC
|
$1.67 B |
-0.000 M
|
![]() Canada
|
![]() Alcon
ALC
|
$45.22 B |
-0.002 M
|
![]() Switzerland
|
![]() Glaukos
GKOS
|
$5.35 B |
0.000 M
|
![]() USA
|
![]() Sun Pharmaceutical
SUNPHARMA.NS
|
$47.34 B |
-0.420 B
|
![]() India
|
![]() Omeros Corporation
OMER
|
$0.40 B |
-0.000 M
|
![]() USA
|
![]() EyePoint Pharmaceuticals
EYPT
|
$0.39 B |
-0.000 M
|
![]() USA
|
Market Cap | = | TARS Stock Price | * | TARS Shares Outstanding |
= | $49.12 | * | 41.61 M | |
= | $2.04 B |